Mediators of Inflammation / 2013 / Article / Fig 6

Research Article

Hmgb1-IL-23-IL-17-IL-6-Stat3 Axis Promotes Tumor Growth in Murine Models of Melanoma

Figure 6

IL-17 activates Stat3 in tumor dependent on IL-6 production. (a) IL-6 level in B16 tumor cells treated for 24 hours with recombinant IL-17 was assessed by quantitative realtime PCR. (b) IL-6 level in B16 tumor cells treated for 24 hours with recombinant IL-17 was assessed by ELISA. (c) Signal-cell suspensions prepared from B16 tumors harvested from WT, WT + anti-γ δ TCR, and IL-17−/− groups were cultured in vitro overnight; supernatants were then collected and assayed for IL-6 levels ( ). (d) Tumor growth in B16 tumor cells inoculated mice from WT + Rat-IgG, WT + anti-IL-6, WT + anti-IL-6 + Ad-IL-17, IL-17−/− + Ad-GFP, and IL-17−/− + Ad-IL-6 groups ( ). (e) Indicating p-Stat3 protein levels (analyzed by Western blot) in B16 tumor tissues from WT + Rat-IgG, WT + anti-IL-6, WT + anti-IL-6 + Ad-IL-17, IL-17−/− + Ad-GFP, and IL-17−/− + Ad-IL-6 groups. The data show means ± SEM of tumor size and are representative of three independent experiments. . NS = not significant.
713859.fig.006a
(a)
713859.fig.006b
(b)
713859.fig.006c
(c)
713859.fig.006d
(d)
713859.fig.006e
(e)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.